Twenty-one patients were selected, eleven for the SiNE group and ten for the control group. The patients for the SiNE group were selected accord ing to the following inclusion criteria: Canine patient with confirmed diagnosis of nasal duct tumor. • Life expectancy of more than 1 month. • Surgery refusal by the owner.